Jennie T. Clarke
( out of 694 reviews )

Jennie T. Clarke, MD

Languages spoken: English

Clinical Locations

Midvalley Health Center

Murray
801-581-2955

Redstone Health Center

Park City
435-658-9200

University of Utah Hospital

Dermatology, Area E
Salt Lake City
801-581-2955

  • Jennie T. Clarke, MD has specialized expertise in caring for patients with rheumatologic skin disease, such as lupus erythematosus and dermatomyositis, and other complex inflammatory dermatologic diseases in both children and adults. She also has a specialized interest in treating the skin conditions that occur commonly in patients with inflammatory bowel disease. In addition, she enjoys caring for general dermatology patients in her clinics. Dr. Clarke is also committed to the education of dermatology residents, and she is the supervising dermatologist of the resident dermatology continuity clinic at the University Hospital.

    Specialties

    Board Certification

    American Board of Dermatology

    Patient Rating

    5.0 /5
    ( out of 694 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    June 29, 2024
    REDSTONE HEALTH CENTER

    Very friendly and competent. Puts you at ease and explains what she is doing.

    June 11, 2024
    REDSTONE HEALTH CENTER

    Dr. Clarke is easy to communicate with and explains everything very well.

    June 08, 2024
    REDSTONE HEALTH CENTER

    Dr Clarke is a caring, knowledgeable. and professional! All of her patients are in great hands!

    June 08, 2024
    REDSTONE HEALTH CENTER

    Dr. Clark is outstanding, is very thorough, listens to and addresses all questions or concerns I may have, is very professional and very pleasant. She truly cares about her patients.

    June 07, 2024
    REDSTONE HEALTH CENTER

    Excellent ability to spot skin cancer, listens well and has a great personality.

    June 03, 2024
    REDSTONE HEALTH CENTER

    Dr. Clarke is the BEST

    June 01, 2024
    REDSTONE HEALTH CENTER

    Great doctor

    June 01, 2024
    REDSTONE HEALTH CENTER

    Dr. Clarke is extremely personable and caring. She is very thorough, knowledgeable and provides excellent treatment resulting in positive results. I very highly recommend Dr. Clarke.

    May 31, 2024
    REDSTONE HEALTH CENTER

    Dr. Clarke is exactly what you would want your doctor to be.

    See More Patient Comments

  • Jennie T. Clarke, MD has specialized expertise in caring for patients with rheumatologic skin disease, such as lupus erythematosus and dermatomyositis, and other complex inflammatory dermatologic diseases in both children and adults. She also has a specialized interest in treating the skin conditions that occur commonly in patients with inflammatory bowel disease. In addition, she enjoys caring for general dermatology patients in her clinics. Dr. Clarke is also committed to the education of dermatology residents, and she is the supervising dermatologist of the resident dermatology continuity clinic at the University Hospital.

    Board Certification and Academic Information

    Academic Departments Dermatology -Primary
    Board Certification
    American Board of Dermatology

    Education history

    Chief Resident Dermatology - Penn State Milton S. Hershey Medical Center Chief Resident
    Dermatology - Penn State Milton S. Hershey Medical Center Resident
    Internship Internal Medicine - Penn State Milton S. Hershey Medical Center Intern
    Medicine - Penn State Milton S. Hershey Medical Center M.D.
    Undergraduate Biology - The College of Wooster B.A.

    Selected Publications

    Journal Article

    1. Hopkins ZH, Jimenez A, Taliercio VL, Clarke JT, Hansen CB, Hull CM, Rhoads JLW, Zone JJ, Sahni VN, Kean J, Secrest AM (2024). Skin-Related Quality of Life During Autoimmune Bullous Disease Course. JAMA Dermatol, 159(11), 1185-1194. (Read full article)
    2. Gociman S, Florell SR, Clarke JT (2023). Cutaneous metastasis as a first sign of adenocarcinoma of the cervix. Dermatol Online J, 29(5). (Read full article)
    3. Bolender CM, Jimenez A, Clarke JT, Willson TM, Stevens VW, Rhoads JLW (2023). Incidence of Dermatomyositis in a Nationwide Cohort Study of US Veterans. JAMA Dermatol, 158(11), 1321-1323. (Read full article)
    4. Jimenez A, Blain K, Khalighi M, Clarke JT, Snook J, Cipriano SD (2021). Neonatal pemphigoid gestationis: An atypical presentation of a rare disease. Pediatr Dermatol, 38(6), 1575-1576. (Read full article)
    5. Blain K, Blue E, Zussman J, Clarke JT (2021). Pruritic, erythematous, arcuate, and serpiginous smooth plaques. JAAD Case Rep, 13, 14-16. (Read full article)
    6. Gonzalez CD, Chung CG, Clarke JT (2016). Painful Perianal Papules in a Middle-Aged Woman. JAMA Dermatol, 152(7), 833-5. (Read full article)
    7. Foulke G, Baccon J, Marks JG, Clarke JT (2012). Antimalarial myopathy in amyopathic dermatomyositis. Arch Dermatol, 148(9), 1100-1. (Read full article)
    8. Goreshi R, Okawa J, Rose M, Feng R, Lee LA, Hansen CB, Bangert CA, Connolly MK, Davis MD, Callen JP, Fett NM, Fakharzadeh SS, Clarke JT, Werth VP (2012). Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM. J Invest Dermatol, 132(4), 1117-24. (Read full article)
    9. Clarke JT (2011). Recognizing and managing reticular erythematous mucinosis: comment on "Clinical features and efficacy of antimalarial treatment for reticular erythematous mucinosis". Arch Dermatol, 147(6), 715. (Read full article)
    10. Clarke JT, Miller JJ, Sceppa J, Goldsmith LA, Long E (2006). Success in the dermatology resident match in 2003: perceptions and importance of home institutions and away rotations. Arch Dermatol, 142(7), 930-2. (Read full article)

    Review

    1. Oldroyd AGS, Callen JP, Chinoy H, Chung L, Fiorentino D, Gordon P, Machado PM, McHugh N, Selva-OCallaghan A, Schmidt J, Tansley SL, Vleugels RA, Werth VP, International Myositis Assessment and Clinical Studies Group Cancer Screening Expert Group, Aggarwal R (2023). International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative. [Review]. Nat Rev Rheumatol, 19(12), 805-817. (Read full article)
    2. Clarke JT, Werth VP (2010). Rheumatic manifestations of skin disease. [Review]. Curr Opin Rheumatol, 22(1), 78-84. (Read full article)
    3. Clarke JT, Werth VP (2006). Therapy of cutaneous lupus erythematosus. [Review]. Expert Rev Dermatol, 1(1), 105-120.

    Letter

    1. Westerdahl S, Hull CM, Clarke JT, Hansen CB, Rhoads JLW (2020). A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1γ antibodies via line immunoassay versus immunoprecipitation. [Letter to the editor]. J Am Acad Dermatol, 84(2), 559-561. (Read full article)
    2. Gonzalez CD, Hansen C, Clarke JT (2019). Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: A retrospective cohort study. [Letter to the editor]. J Am Acad Dermatol, 81(3), 859-860. (Read full article)

  • News & Podcasts

    News